Day 1

Thursday, August 15th

  • The Role of Toxic Chemicals in Neurological and Psychiatric Disorders

    Toxic chemicals frequently disrupt brain function through inhibition of mitochondrial function. The evidence for toxic chemical exposure in neurological and psychiatric disorders will be presented based on the medical literature. Case studies of patients with toxic exposures and tremors, amyotrophic lateral sclerosis, and Huntington’s disease will be discussed.

  • Orthomolecular Medicine and Schizophrenia

    In this presentation, Dr. Greenblatt will discuss the history of orthomolecular medicine, specifically the work of Dr. Linus Pauling and Dr. Abram Hoffer in treating schizophrenia, and the efficacy of the current pharmacological treatment model. Original orthomolecular concepts developed by Dr. Hoffer will be updated to review the current understanding of nutritional and metabolic factors in the treatment of psychosis and schizophrenia. Research completed over the last few years will be presented on specific nutritional deficiencies related to the etiology and treatment course for schizophrenia.

  • Metabolic Products and Mental Health: How Fungal, Bacterial, Mitochondrial, and Other Key Compounds Influence the Brain

    Organic acids are chemical compounds excreted in the urine that are products of metabolism. High levels or low levels of various organic acids in the body can have a tremendous impact on the brain and mental health. This lecture will review several of these organic acids, including specific fungal, bacterial, and mitochondrial markers clinically relevant for various brain and nervous system disorders.

  • Targeted Nutrition for Brain Health: Using Omega-3, Cholesterol, CDP-Choline, and More as Interventions

    The human brain is extremely metabolically active and uses up more oxygen than other organs in the body. It also contains a great deal of unsaturated fat, cholesterol, and sulfur amino acids. A wide variety of nutritional factors that may be suboptimal in the diet are needed to ensure efficient brain function including cholesterol, fatty acids, lithium, CDP choline, carnitine, short chain fatty acids, and many others. Dr. Shaw will focus on how to maintain the best possible brain function by optimizing the right amounts of these cofactors.

  • The Impact of Candida and Clostridia Infections on the Brain

    Clostridia bacteria and invasive candida are known to produce various toxic compounds that can negatively affect a person’s health, including brain function. This lecture will explain how these pathogens can adversely affect brain and nervous system function.

  • Microorganisms and Their Effect on Mental Health

    Abnormally high numbers of microorganisms in the gastrointestinal tract are often present in virtually every type of neurological and behavioral disorder including depression, OCD, and schizophrenia, autism, and ADHD. Certain species of Candida and Clostridia bacteria are especially prevalent. Autoimmunity to brain proteins induced by cross-reactive antibodies against Streptococcus bacteria has been implicated as a significant factor in Tourette’s syndrome, tic disorders, OCD, autism, and eating disorders. Tests and nutritional treatments available for these disorders will be discussed in detail.

  • The Hidden Threat of Mycotoxins to the Brain, Part 1 and 2

    Mold and fungi are ubiquitous in the environment. However, in "WDB" (water damaged buildings), and even some foods, mold can become a sinister force affecting physical and mental health. Not all molds are toxic and many just cause respiratory issues, but a subset of molds produce mycotoxins; powerful neurotoxins that can have a profound effect on the brain and mental health. The effects of mycotoxins, as well as testing, diagnosis, and treatment options will be discussed.

  • Gut Bacteria and Brain Function

    Gut bacteria has been shown to affect brain development, mood, and a wide range of behaviors. HPHPA, a clostridia bacteria metabolite in the gastrointestinal tract has been shown to affect mood and behavior. In this presentation, Dr. Greenblatt will discuss specific case studies of psychiatric symptoms related to HPHPA elevations.

  • Mycotoxin Exposure: Correlations with Autism, Parkinson’s, and Other Disorders

    Recent discoveries have revealed strong correlations between mycotoxin exposure and specific neurological disorders, including autism and Parkinson’s disease. In the presentation, Dr. Shaw will review the latest evidence in the literature about these correlations. He will also discuss a recent case of autism that was rapidly recovered after antifungal treatment.

  • Solving the Brain Puzzle: Recovery Potential for Neurodegenerative Disorders

    Most of our neurodegenerative diseases are triggered or aggravated by toxic chemicals and neurotoxins. In this presentation, Dr. Code will review specific strategies of testing, treatment, and recovery from disorders like MS, ALS, Alzheimer’s disease, and Parkinson’s disease. Case presentations will be included to assist with clinical application.

  • Exosome Therapy: An Effective Adjunct Treatment for Autism and Other Neurodegenerative Disorders